Navigation Links
Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment
Date:12/4/2009

RARITAN, N.J., Dec. 4 /PRNewswire/ -- Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur more often in people who said they had been diagnosed with epilepsy versus those without an epilepsy diagnosis, according to a survey of approximately 173,000 households across the U.S.

Findings from "CNS-Related Comorbidities in Individuals with Self-Reported Epilepsy - Data from the National Survey of Epilepsy, Comorbidities and Health Outcomes" will be detailed in a platform presentation on Dec. 7 at the 2009 American Epilepsy Society (AES) Annual Meeting in Boston. The analysis explores the importance of identifying these Central Nervous System (CNS)-related comorbid conditions, and their potential impact on the clinical management of epilepsy.

The survey results are one of eight presentations supported by Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) at the AES Meeting.

Saturday, Dec. 5: 1-8 p.m. (author presentations 2-3 p.m.)

  • Poster 1.136: "Tolerability of Carisbamate as Adjunctive Treatment of Partial Onset Seizures in Adults in Three Double-blind, Randomized, Placebo-controlled Studies"; M.R. Sperling, E. Faught, J. Schmitt, F. Wiegand, G. Novak
  • Poster 1.134: "Carisbamate as Adjunctive Treatment of Partial Onset Seizures in Adults: Results at 18 Months From an Ongoing Open-label Extension of a Double-blind, Randomized, Dose-ranging Study"; S. Lippmann, W. Rosenfeld, F. Wiegand, J. Schmitt, G. Novak
  • Poster 1.329: "Improving Neurologist-Patient Communication to Promote More Effective Assessment of Side Effects and Comorbidities in Epilepsy: Results of a Phase II Communication Study"; J.M. Stern, D. Labiner, F. Gilliam, P. Penovich, M. Onofrey, C. Eagan, E. Mathis, G.L. Holmes
  • Poster 1.127: "An Open-label Extension of Two Placebo-contro
    '/>"/>

SOURCE Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Looking Older? How Square is Your Jaw Line?
2. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
3. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
4. Clinical Trial Best Practices: Savvy Marketers Plan Ahead with Early Communication Strategies
5. Patient Enrollment in Urgent(R) PC SUmiT Clinical Trial Completed Ahead of Schedule
6. Staying One Step Ahead of Osteoporosis
7. Combined Pharma Event Visitor Numbers 5% Ahead of 2008 Frankfurt Record
8. CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence
9. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... N.Y. , May 22, 2013  MGT Capital ... Company will present at the Second Annual Marcum LLP ... New York City at the Grand ... and Chief Executive Officer, will update investors and answer ... The Company,s presentation is scheduled to begin at ...
(Date:5/22/2013)... MAPLE GROVE, Minn. , May 22, ... today announced the successful completion of its ... (extended-release topiramate), an internally developed program for ... the company,s proprietary formulation technology.  USL255 is ... and reduce fluctuations in topiramate blood levels ...
(Date:5/22/2013)... , May 22, 2013 Hemoglobin A1C ... patients with Type 2 diabetes, while modest improvements ... health outcomes and can lead to substantial healthcare ... the International Society for Pharmacoeconomics and Outcomes Research ... two studies, sponsored by Valeritas, makers of the ...
Breaking Medicine Technology:MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 3MGT Capital Investments, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 4Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 2Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 3Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6
... designed for more uniform drug ... ... Boston,Scientific Corporation (NYSE: BSX ) today announced comprehensive data ... historically controlled trials, which evaluate,the TAXUS(R) Liberte(R) Paclitaxel-Eluting Stent System in ...
... with Kogenate FS Reduces the,Risk of Joint Damage ... Damage, BERKELEY, Calif., Oct. 10 Bayer ... Drug Administration (FDA) has,approved routine prophylaxis with Kogenate(R) ... bleeding episodes and the risk of,joint damage in ...
Cached Medicine Technology:Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 2Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 3Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 4Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 5Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent 6FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5
(Date:5/22/2013)... 2013 Seva Call (Save-A-Call) has launched ... businesses and connects consumers to the right available professional ... time to handle personal matters than the national and ... from work. So, they really can’t afford the 30 ... available professional. , Now, Detroit residents will be able ...
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Following ... the fitness franchise Fit Body Boot Camp ... Annual 1,000 lb. Meltdown Challenge starting on June 3rd ... Davidson Centre 601 Durham Street, Kincardine, Ontario.     , Fit ... to inspire and motivate local community residents to lose ...
(Date:5/22/2013)... May 22, 2013 Hypervibe, a leader ... , announced today that the company’s US division will ... and Monday. Military personnel ordering the Hypervibe Performance during ... they show a valid military ID. Non-military customers receive ... values commitment, honor, and integrity. These are values that ...
(Date:5/22/2013)... 2013 Asthma, a disorder that causes ... causes wheezing, shortness of breath, chest tightness and coughing ... muscles surrounding the airways become tight and the lining ... air that can pass. Asthma attacks can last for ... severely restricted. Reuters reports that there is ...
(Date:5/22/2013)... 22, 2013 Patients with type 1 ... have better glycemic control as measured by significantly lower ... condition with insulin injections, according to new findings from ... conducted by Kantar Health . The research was ... (International Society for Pharmacoeconomics and Outcomes Research) in New ...
Breaking Medicine News(10 mins):Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 2Health News:Kincardine Fitness Center Promotes 2nd Annual 1,000 lb. Meltdown Challenge to Fight Obesity With All Proceeds Raised Going to Local Charity 3Health News:Hypervibe Whole Body Vibration Offers First-Ever Sale This Memorial Day Weekend 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research 2Health News:Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research 3
... is,pursuing its external growth strategy in Italy and the ... development in Italy with the acquisition,of Galileo, a major ... stock lenses under its own brand, which is widely,recognized ... a prescription laboratory in Milan and generates EUR13 million ...
... between father,s, but not mother,s, weight and elevated enzymes ... fathers had early-onset obesity are at increased risk for ... U.S. study. , Researchers evaluated 1,732 children, average age ... long-term study of families in Framingham, Mass. The researchers ...
... 2008 PAHEF is,pleased to join Harvard University,s ... partner in the bi-annual conference,Frontiers of Innovation: 20 ... 31st through today. On Monday evening, the executive,director ... (PAHEF), Mr.,Edward Kadunc, discussed multisector partnerships in tackling ...
... reducing food intake 30% decreased infection-fighting cells , , THURSDAY, April ... remember whether it,s "starve a cold, feed a fever" or ... , A study of deer mice has found that reducing ... system. The findings are published in the May/June issue of ...
... the Stars, The View Hosts Agree: March of Dimes,Fund-raising Walk ... 2008 It doesn,t,matter what you call it, March of ... Babies(SM) will be held the last weekend in April in ... their support to the March of,Dimes work to help moms ...
... Fifth Third Bank,today announced a strategic alliance with ... revenue cycle management services to,the healthcare industry, that ... for healthcare providers. The alliance,will enable Fifth Third ... from,claims to payments -- and integrate the data ...
Cached Medicine News:Health News:Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States 2Health News:Dads' Early-Onset Obesity Linked to Liver Disease in Kids 2Health News:PAHEF Discusses Neglected Diseases and Disaster Preparedness with Innovative Leaders 2Health News:Eating Less May Hinder Immune System 2Health News:March For Babies Has Celebrity Support -- Now It Needs Yours 2Health News:Fifth Third Bank Teams with Leading Healthcare Providers to Deliver a Claims-to-Payment Business Intelligence Platform 2Health News:Fifth Third Bank Teams with Leading Healthcare Providers to Deliver a Claims-to-Payment Business Intelligence Platform 3
Full Handle Laseredge Implant Blade Knife, 4.0 mm straight. Blade dimension: 15.2 mm x 4.0 mm x 3.0 mm x 1.6 mm....
Full Handle Laseredge Crescent Blade Knife, straight. Blade tip dimension: 12.7 mm x 2.0 mm x 3.8 mm....
Full Handle Laseredge Stab Blade Knife, 45 blade. Blade tip dimension: 8.9 mm x 1.9 mm x 1.9 mm....
Full Handle Laseredge Stab Blade Knife, 15 blade. Blade tip dimension: 11.1 mm x 1.5 mm x 5.7 mm....
Medicine Products: